Dragonfly, Therapeutics Dragonfly Therapeutics inicia el estudio de fase 1 / 1b de su inmunoterapia con IL-2 07.08.2025 - 18:03:25 Dragonfly Therapeutics, Inc. Massachusetts View original content:https://www.prnewswire.com/news-releases/dragonfly-therapeutics-inicia-el-estudio-de-fase-11b-de-su-inmunoterapia-con-il-2-302006807.html
